Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel

✍ Scribed by Roque, Dana M.; Buza, Natalia; Glasgow, Michelle; Bellone, Stefania; Bortolomai, Ileana; Gasparrini, Sara; Cocco, Emiliano; Ratner, Elena; Silasi, Dan-Arin; Azodi, Masoud; Rutherford, Thomas J.; Schwartz, Peter E.; Santin, Alessandro D.

• Book ID: 121403624
• Publisher: Springer
• Year: 2013
• Tongue: English
• Weight: 422 KB
• Volume: 31
• Category: Article
• ISSN: 0262-0898
• DOI: 10.1007/s10585-013-9614-5